Skip to main content
Top navigation
  • Sustainability reports
  • Focus area: Increase resource efficiency
  • Governance
  • Please fill out this field

Main navigation

    • Our offering
        • Solids & others
            • Manufacturing
                • Solids
                • Semi-solids
                • Liquids
                • Pharmaceutical packaging
                • Controlled drugs
                • High Potent
        • Sterile delivery
            • Manufacturing
                • Sterile vial filling
                • PFS and cartridges
                • Lyophilisation
                • Blow-fill-seal
                • Ampoules
            • Specialised services
                • Ophthalmics
                • Beta-lactams
                • Vaccine manufacturing
        • Advanced Bio
            • Modalities & services
                • xRNA therapies
                • Virus & viral vectors
                • Microbial & live biotherapeutic products
                • Recombinant proteins
            • Continuous manufacturing
            • Innovations & collaborations
        • Additional services
            • ReciPredict
            • Analytical services
            • Regulatory
            • Parenteral drug development
            • New product introduction
                • Technology Transfer
                • Product development
    • Resources
    • About us
        • About us
            • Our leadership
            • Why partner with us
            • Locations
        • Sustainability
            • Sustainability reports
            • Sustainability strategy
            • Net Zero commitment
            • Governance
        • News & Events
            • Press releases
            • Events
    • Careers
        • Careers
            • Who we are
            • Working with us
            • What you can do
            • Job search
    • Contact
Linkedin
Contact
Please fill out this field
No banner Image

Press releases

  • Home
  • About us
  • Press releases
  • Facebook
  • Linkedin
  • Twitter
  • Email

BU-NOT-SET

CONTACT US
December 19 2023
Recipharm harmonizes its global quality operations with Veeva Vault Quality
December 11 2023
ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas' LNP formulations
November 21 2023
Marc Funk to transition to Recipharm's Board of Directors; Greg Behar appointed new CEO; Inhaled Business to standalone in 2024
November 21 2023
Recipharm annonce cesser ses activités mi-2025 sur son site de Monts, France, et va déployer ses efforts pour la recherche d'un repreneur
September 09 2023
Earthquake in Morocco
September 05 2023
Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy
July 11 2023
Recipharm's new analytical lab brings impressive testing capabilities to global markets
June 05 2023
Statement from Arranta Bio on settlement of Thermo Fisher litigation
May 04 2023
Recipharm makes senior appointment to head up biologics business unit, ReciBioPharm
May 02 2023
FDA approves the manufacture of new microbiome-based therapeutic VOWST™ at Recipharm site

Pagination

  • First page
  • Previous page
  • …
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • …
  • Next page
  • Last page

Footer Webfrom

contact form

Let’s discuss your 
next project

Share your details and start your journey with our global CDMO team.

Stay updated
https://se.linkedin.com/company/recipharm https://www.youtube.com/channel/UCr-bw7pCCkYZfeImOwTfNRg
Footer
  • Privacy policy
  • Cookies
  • Website terms
  • Sitemap
  • Cookie settings
  • Terms & conditions
  • Code of Conduct
© 2026

Recipharm AB. All rights reserved. RECIPHARM® is a registered trademark owned by Recipharm AB.

Delivered by Investisdigital [iDX]